Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) EPS (Basic): 2020-2025

Historic EPS (Basic) for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to -$0.00.

  • Molecular Partners Ag's EPS (Basic) rose 30.65% to -$0.00 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.53, marking a year-over-year increase of 88.65%. This contributed to the annual value of -$1.81 for FY2024, which is 14.12% up from last year.
  • According to the latest figures from Q3 2025, Molecular Partners Ag's EPS (Basic) is -$0.00, which was up 99.94% from -$0.67 recorded in Q2 2025.
  • Molecular Partners Ag's 5-year EPS (Basic) high stood at $6.57 for Q3 2023, and its period low was -$21.75 during Q4 2023.
  • Moreover, its 3-year median value for EPS (Basic) was -$0.00 (2025), whereas its average is -$0.50.
  • The largest annual percentage gain for Molecular Partners Ag's EPS (Basic) in the last 5 years was 4,537.65% (2023), contrasted with its biggest fall of 1,325.18% (2023).
  • Quarterly analysis of 5 years shows Molecular Partners Ag's EPS (Basic) stood at -$0.61 in 2021, then slumped by 151.25% to -$1.53 in 2022, then slumped by 1,325.18% to -$21.75 in 2023, then soared by 91.46% to -$1.86 in 2024, then soared by 30.65% to -$0.00 in 2025.
  • Its EPS (Basic) stands at -$0.00 for Q3 2025, versus -$0.67 for Q2 2025 and -$0.00 for Q1 2025.